Annette Logan-Parker: A Hemophilia B Breakthrough – From Weekly Infusions to One Treatment
Annette Logan-Parker, Founder and Chief Advocacy and Innovation Officer at Cure 4 The Kids Foundation, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared on LinkedIn:
”He flew from Arizona to Las Vegas for a single infusion…and never needed another one.
For 39 years, this patient lived with hemophilia B.
That meant intravenous infusions of clotting factor every week, sometimes multiple times a week, just to prevent a bleed that could put him in the hospital.
Every week. For nearly four decades. That was his life.
In 2024, he came to our clinic and received Hemgenix (an FDA-approved gene therapy that delivers a working copy of the gene his body was missing).
One infusion. One afternoon.
More than a year later, his body is producing its own clotting factor. No more weekly treatments. No more planning his entire life around his next infusion.
Cure 4 The Kids Foundation was the first center in Nevada to administer this therapy, and one of only a handful on the entire West Coast.
This is what research looks like when it reaches the bedside. And it’s why Research Recognition Week matters.
Read the full story on our blog, including what families need to know about gene therapy, who’s eligible, and what’s coming next.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot MissÂ
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care